GEN vs SER · P/E 17, rev $5.00B vs rev $56.0K
Gen Digital Inc. (GEN) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. SER currently screens at market cap $29.7M.
Not investment advice. Open the GEN and SER stock pages for the full models.
Not investment advice.